Ignite Creation Date:
2025-12-24 @ 12:35 PM
Ignite Modification Date:
2026-02-02 @ 6:19 PM
Study NCT ID:
NCT02230761
Status:
COMPLETED
Last Update Posted:
2016-02-08
First Post:
2014-08-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Study of XAF5 (XOPH5) Ointment for Reduction of Excess Eyelid Fat (Steatoblepharon)
Sponsor:
Topokine Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09
Start Date Type:
None
Primary Completion Date:
2014-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-12
Completion Date Type:
ACTUAL
First Submit Date:
2014-08-28
First Submit QC Date:
None
Study First Post Date:
2014-09-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-11-19
Results First Submit QC Date:
None
Results First Post Date:
2016-02-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-01-09
Last Update Post Date:
2016-02-08
Last Update Post Date Type:
ESTIMATED